Baillie Gifford & Co
GMED icon

Baillie Gifford & Co’s Globus Medical GMED Stock Holding History

Baillie Gifford & Co’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-91,084
Closed -$6.24M – 285
2024
Q2 		$6.24M Buy
91,084
+18
+0% +$1.07K ﹤0.01% 231
2024
Q1 		$4.88M Sell
91,066
-961
-1% -$51.7K ﹤0.01% 240
2023
Q4 		$4.9M Sell
92,027
-17,848
-16% -$870K ﹤0.01% 240
2023
Q3 		$5.46M Buy
109,875
+215
+0.2% +$12K 0.01% 233
2023
Q2 		$6.53M Sell
109,660
-436
-0.4% -$24.8K 0.01% 235
2023
Q1 		$6.24M Buy
110,096
+48,109
+78% +$3.08M 0.01% 238
2022
Q4 		$4.6M Sell
61,987
-2,090
-3% -$142K ﹤0.01% 247
2022
Q3 		$3.82M Hold
64,077
– – ﹤0.01% 251
2022
Q2 		$3.6M Buy
+64,077
New +$4.21M ﹤0.01% 252

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Baillie Gifford & Co's GMED Position: Q3 2024 in Review

Baillie Gifford & Co sold out of Globus Medical (GMED) in Q3 2024, closing a stake of 91,084 shares — an estimated $6.24M sold.

Baillie Gifford & Co first reported a position in GMED in Q2 2022 and held it in 9 quarters. The position peaked at $6.53M in Q2 2023. 449 funds tracked by Wall St. Rank hold GMED as of Q3 2024.

  • Baillie Gifford & Co reported no remaining Globus Medical position as of Q3 2024 after selling out during the quarter.
  • Baillie Gifford & Co sold 91,084 Globus Medical shares in Q3 2024, an estimated $6.24M.
  • Baillie Gifford & Co first reported a position in Globus Medical in Q2 2022 and held it in 9 quarters.
  • Baillie Gifford & Co's Globus Medical position peaked at $6.53M in Q2 2023.
  • 449 funds tracked by Wall St. Rank held Globus Medical as of Q3 2024.

Based on Baillie Gifford & Co's 13F filing for Q3 2024, filed 5 Nov 2024.